The Chase Group announces another successful leadership recruitment with the placement of the Vice President of Drug Safety at Ionis Pharmaceuticals. Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary anti-sense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development.
Vice President of Drug Safety for Ionis Pharmaceuticals Secured
The Chase Group announces another successful leadership recruitment with the placement of the Vice President of Drug Safety at Ionis Pharmaceuticals. Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary anti-sense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development.- Categories: Biotechnology, Life Sciences, Pharmaceutical, Research & Development
Corporate Communications Executive Secured for Ipsen Biopharmaceuticals
The Chase Group, Inc. is pleased to announce the successful completion of a search for a Vice President of Internal and External Communications for Ipsen…
Esperion Therapeutics Taps The Chase Group to Fill Newly Created Role
Esperion Therapeutics has retained The Chase Group, Inc. to secure an Executive Director, Project Management. This newly created key leadership position will elevate internal collaboration…
Vice President of Drug Safety for Ionis Pharmaceuticals Secured
The Chase Group announces another successful leadership recruitment with the placement of the Vice President of Drug Safety at Ionis Pharmaceuticals. Ionis is the leading…-
Ionis Engages The Chase Group to Continue Building QA Team
Ionis Pharmaceuticals has retained The Chase Group, Inc. to help build their GCP QA team. This dynamic role requires demonstrated expertise in GCP QA/QC with… -
Ipsen Retains The Chase Group for Senior Marketers
Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership as they build world class marketing organizations for both the… 
Head of Regulatory Affairs Secured for Marinus
The Chase Group recently completed a highly competitive search for the Head of Regulatory Affairs for Marinus Therapeutics. Marinus is a clinical biopharmaceutical company focused…